The scientists say easing restrictions too soon could allow more sinister versions of the virus to escape and seed a new outbreak.
Dating apps may be enjoying a boom, but the love lives of singles are suffering in lockdown.
Identity and access management service Okta today launched its new design system, both for its own corporate and brand use, but also as an open-source project under the Apache 2.0 license. The Odyssey
Unlike other jabs, which require two doses several weeks apart, the J&J shot is administered in a single injection.
Scientists hope they can then attach live coral to 3D-printed backbones, before placing them in the ocean to grow new reefs.
Both Google and social media giant Facebook are fighting government plans to make tech giants pay for news content.
Sky News speaks to Gary Numan about artist revenue from streaming as a Parliamentary inquiry looks into the economics.
Scientists will continue to follow thousands of UK health workers to see if the protection against the virus lasts even longer.
An official says the problem may explain why the government struggled to publish vaccination figures until Wednesday.
Beer manufacturing usually produces a high level of carbon dioxide, but a new technique will harness and turn it into plant food.
Fintech startup Revolut is launching its own acquiring solution. With this move, the company is competing directly with Stripe, Adyen, Braintree or Checkout.com. This is an in-house product and not ju
Doses of the jab 95%-effective jab could begin in the Spring, but it has yet to be approved by the UK regulator.
Researchers claims the error "likely propelled England to a different stage of COVID-19 spread" at the start of the second wave.
Google has updated its flagship iPhone apps with support for home screen widgets, a new feature of iOS 14. The company announced today it’s rolling out new widgets for Gmail, Google Drive, Googl
Researchers say the spray protects against COVID-19 and can also prevent the virus being passed from person to person.
Some 560 healthy adult volunteers took part in the phase two trials, where they were given two doses of the vaccine, or a placebo.
Oral rinses containing 0.07% of the ingredient cetylpyridinium chloride show "promising signs" of reducing COVID-19.
简体中文
